Edward Conner
Chief Tech/Sci/R&D Officer bij THIRD HARMONIC BIO, INC.
Vermogen: - $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Edward Conner
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
122
| Subsidiary | Biotechnology | 122 |
Public Company | Biotechnology | 23 | |
Subsidiary | Biotechnology | 21 | |
Public Company | Pharmaceuticals: Major | 16 | |
13
| Extinct | Pharmaceuticals: Major | 13 |
Public Company | Pharmaceuticals: Major | 13 | |
Public Company | Biotechnology | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Edward Conner via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Compliance Officer Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member | |
INTERMUNE INC | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Investor Relations Contact | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree President Graduate Degree Graduate Degree | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Private Equity Investor | |
University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Knox College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
University of Michigan | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Enobia Pharma, Inc.
Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
RELYPSA INC | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Administrative Officer Director/Board Member | |
Haas School of Business | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Chairman Director/Board Member | |
PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Chairman | |
Cydan LLC
Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA. | Medical Distributors | Director/Board Member Founder Director/Board Member | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Vtesse, Inc.
Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
DENALI THERAPEUTICS INC. | Biotechnology | Founder Director/Board Member Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 46 |
Zwitserland | 2 |
Verenigd Koninkrijk | 2 |
Canada | 2 |
Ierland | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 17 |
Finance | 4 |
Commercial Services | 3 |
Health Services | 2 |
Operationeel
Director/Board Member | 591 |
Corporate Officer/Principal | 291 |
Independent Dir/Board Member | 220 |
Chairman | 112 |
Chief Tech/Sci/R&D Officer | 92 |
Sterkste connecties
Insiders | |
---|---|
André S. Hoffmann | 52 |
Charlie Sanders | 38 |
Louis Lange | 35 |
William Ringo | 32 |
Robert Perez | 31 |
Mette Agger | 30 |
Joseph Zakrzewski | 30 |
Karen Smith | 29 |
J. Kenneth Charles Knowles | 29 |
David Bonita | 27 |
Patrick Yang | 27 |
Mark Iwicki | 26 |
Debra Reed-Klages | 26 |
Mark Chin | 25 |
Marc Tessier-Lavigne | 24 |
- Beurs
- Insiders
- Edward Conner
- Bedrijfsconnecties